Mary E. Enama

6.5k citations
30 papers · 2.3k · h-index 21

Impact in

  • Virology top 1%
    • HIV Research and Treatment
    • Viral Infections and Vectors
    • SARS-CoV-2 and COVID-19 Research
    • Viral Infections and Outbreaks Research
    • Viral gastroenteritis research and epidemiology

Papers in

    • Influenza Virus Research Studies 9
    • Hepatitis B Virus Studies 6
    • HIV Research and Treatment 7

Mary E. Enama

30 papers receiving 2.2k citations

Peers

Mary E. Enama
Comparison fields: 5 of 87
  • Virology 445
  • Infectious Diseases 1.1k
  • Immunology 592
  • Epidemiology 713
  • Public Health, Environmental and Occupational Health 390
Replace Koert J. Stittelaar with:
Koert J. Stittelaar Netherlands
Tamara Berthoud United Kingdom
Pathom Sawanpanyalert Thailand
Matthew G. Cottingham United Kingdom
Azaibi Tamin United States
Koen K. A. Van Rompay United States
Dirk Eggink Netherlands
Frances K. Newman United States
John Copps Canada
Otfried Kistner Austria
Mary E. Enama relative to Koert J. Stittelaar Netherlands Koert J. Stittelaar's profile →
Citations per field
00.5×2.7×
Koert J. Stittelaar · 1×
Citations per year

Countries citing papers authored by Mary E. Enama

Since Specialization
Citations

This map shows the geographic impact of Mary E. Enama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Enama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Enama more than expected).

Fields of papers citing papers by Mary E. Enama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Enama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Enama. The network helps show where Mary E. Enama may publish in the future.

Co-authors

The 25 scholars most cited alongside Mary E. Enama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary E. Enama Line = papers co-authored together Mary E. Enama links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006228
2 2008199
3 2014183
4 2006170
5 2011150
6 2006150
7 2010145
8 2007133
9 2011116
10 2010101
11 199798
12 200796
13 201395
14 200673
15 201361
16 201243
17 200743
18 199734
19 201232
20 201824

About Mary E. Enama

Mary E. Enama is a scholar working on Epidemiology, Virology, Immunology, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 30 papers that have together received 2.3k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (9 papers), HIV Research and Treatment (7 papers), Hepatitis B Virus Studies (6 papers), Immunotherapy and Immune Responses (4 papers), Mosquito-borne diseases and control (3 papers), Viral Infections and Outbreaks Research (2 papers), Viral Infections and Vectors (2 papers) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Virology (445 citations), Infectious Diseases (1.1k citations), Immunology (592 citations), Epidemiology (713 citations) and Public Health, Environmental and Occupational Health (390 citations). Mary E. Enama has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Robert T. Bailer, Richard A. Koup, Barney S. Graham, Gary J. Nabel, John R. Mascola, Mario Roederer, Ingelise J. Gordon, Charla Andrews, Julie E. Ledgerwood and Phillip L. Gomez. Their work appears in journals such as PLoS ONE, The Journal of Infectious Diseases, Vaccine, Clinical and Vaccine Immunology and Contemporary Clinical Trials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact